Assessment of DNA damage in postmenopausal women under hormone replacement therapy

Maturitas

Volumn 51, Issue 3, 2005, Pages 280-285

  Ozcagli, Eren ^a   Sardas, Semra ^a   Biri, Aydan ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Alkaline comet assay; Hormone replacement therapy; Postmenopausal women

Indexed keywords

CONJUGATED ESTROGEN; DNA; MEDROXYPROGESTERONE; TIBOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DOSE RESPONSE; FEMALE; GENOTOXICITY; HORMONE SUBSTITUTION; HUMAN; LEUKOCYTE; MENOPAUSAL SYNDROME; PATIENT CODING; POSTMENOPAUSE; SCORING SYSTEM; STANDARDIZATION;

CASE-CONTROL STUDIES; COMET ASSAY; DNA; DNA DAMAGE; ESTROGEN RECEPTOR MODULATORS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; NORPREGNENES; POSTMENOPAUSE; QUESTIONNAIRES; RISK FACTORS;

EQUIDAE;

EID: 20644460135     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.08.010     Document Type: Article

References (35)

1. R.A. Moore Livial: a review of clinical studies Br J Obstet Gynaecol 106 1999 1 21
2. J.C. Gallagher, D.J. Baylink, R. Freeman, and M. McClung Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies J Clin Endocrinol Metab 86 2001 4717 4726
3. L. Speroff Postmenopausal hormone therapy and the risk of breast cancer Maturitas 32 1999 123 129
4. L.A. Brinton, and R.N. Hoover Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group Obstet Gynecol 81 1993 265 271
5. M.C. Pike, and R.K. Ross Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer Steroids 65 2000 659 664
6. G.A. Colditz, K.M. Egan, and M.J. Stampfer Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies Am J Obstet Gynecol 168 1993 1473 1480
7. B.S. Hundal, V.S. Dhillon, and I.S. Sidhu Genotoxic potential of estrogens Mut Res 389 1997 173 181
8. J. Sierens, J.A. Hartley, M.J. Campbell, A.J. Leathem, and J.V. Woodside Effect of phytoestrogen and antioxidant supplementation on oxidative DNA damage assessed using the comet assay Mut Res 485 2001 169 176
9. F. Kassie, W. Parzefall, and S. Knasmuller Single cell gel electrophoresis assay: a new technique for human biomonitoring studies Mut Res 463 2000 13 31
10. A.V. Carrano, and A.T. Natarajan International Commission for Protection Against Environmental Mutagens and Carcinogens, ICPEMC publication no. 14. Considerations for population monitoring using cytogenetic techniques Mut Res 204 1988 379 406
11. O.I. Kalantzi, R. Hewitt, and K.J. Ford Low dose induction of micronuclei by lindane Carcinogenesis 25 2004 613 622
12. C. Davis, S. Bhana, A.J. Shorrocks, and F.L. Martin Oestrogens induce G(1) arrest in benzo[a]pyrene-treated MCF-7 breast cells whilst enhancing genotoxicity and clonogenic survival Mutagenesis 17 5 2002 431 438
13. N.P. Singh, M.T. McCoy, R.R. Tice, and E.L. Schneider A simple technique for quantification of low levels of DNA damage in individual cells Exp Cell Res 175 1988 184 191
14. A.R. Collins The comet assay. Principles, applications, and limitations Meth Mol Biol 203 2002 163 177
15. A. Biri, E. Civelek, B. Karahalil, and S. Sardas Assessment of DNA damage in women using oral contraceptives Mut Res 521 2002 113 119
16. L. Karabiyik, S. Sardas, U. Polat, N.A. Kocaba, and A.E. Karakaya Comparison of genotoxicity of sevoflurane and isoflurane in human lymphocytes studied in vivo using the comet assay Mut Res 492 2001 99 107
17. T.R. Smith, M.S. Miller, K.K. Lohman, L.D. Case, and J.J. Hu DNA damage and breast cancer risk Carcinogenesis 24 2003 883 889
18. S. Colleu-Durel, N. Guitton, K. Nourgalieva, J. Leveque, B. Danic, and C. Chenal Genomic instability and breast cancer Oncol Rep 8 2001 1001 1005
19. F. Kayikcioglu, M. Gunes, V. Baltaci, M. Kocak, I. Alpas, and A. Haberal Sister-chromatid exchange frequencies in postmenopausal hormone replacement patients Mut Res 452 2000 37 39
20. X. Liu, J. Yao, and E. Pisha Oxidative DNA damage induced by equine estrogen metabolites: role of estrogen receptor alpha Chem Res Toxicol 15 2002 512 519
21. V.S. Dhillon, and I.K. Dhillon Genotoxicity evaluation of estradiol Mut Res 345 1995 87 95
22. N. Joseph-Lerner, M. Fejgin, I. Ben-Nun, C. Legum, and A. Amiel The correlation between the frequency of sister-chromatid exchange and human reproductive hormones Mut Res 300 1993 247 252
23. E. Yared, T.J. McMillan, and F.L. Martin Genotoxic effects of oestrogens in breast cells detected by the micronucleus assay and the Comet assay Mutagenesis 17 2002 345 352
24. H.S. Feigelson, and B.E. Henderson Estrogens and breast cancer Carcinogenesis 17 1996 2279 2284
25. M.S. Wolff, G.W. Collman, J.C. Barrett, and J. Huff Breast cancer and environmental risk factors: epidemiological and experimental findings Annu Rev Pharmacol Toxicol 36 1996 573 596
26. E.L. Lewis-Michl, J.M. Melius, and L.R. Kallenbach Breast cancer risk and residence near industry or traffic in Nassau and Suffolk Counties Long Island, New York Arch Environ Health 51 1996 255 265
27. W.E. Morton Major differences in breast cancer risks among occupations J Occup Environ Med 37 1995 328 335
28. A. Hartmann, H. Blaszyk, J.S. Kovach, and S.S. Sommer The molecular epidemiology of p53 gene mutations in human breast cancer Trends Genet 13 1997 27 33
29. F.I. Sahin, I. Sahin, M.A. Ergun, and O.F. Saracoglu Effects of estrogen and alendronate on sister chromatid exchange (SCE) frequencies in postmenopausal osteoporosis patients Int J Gynaecol Obstet 71 2000 49 52
30. H.J. Kloosterboer Tibolone: a steroid with a tissue-specific mode of action J Steroid Biochem Mol Biol 76 2001 231 238
31. P. Albertazzi, R. Di Micco, and E. Zanardi Tibolone: a review Maturitas 30 1998 295 305
32. C. Egarter, A. Topcuoglu, S. Vogl, and M. Sator Hormone replacement therapy with tibolone: effects on sexual functioning in postmenopausal women Acta Obstet Gynecol Scand 81 2002 649 653
33. A. Gompel, M. Chaouat, D. Jacob, J.Y. Perrot, H.J. Kloosterboer, and W. Rostene In vitro studies of tibolone in breast cells Fertil Steril 78 2002 351 359
34. H. Gokaslan, O. Oktem, F. Durmusoglu, and F. Eren Apoptosis in the endometrium of postmenopausal women receiving tibolone Gynecol Obstet Invest 56 2003 124 127
35. H.J. Kloosterboer, W.G. Schoonen, G.H. Deckers, and J.G. Klijn Effects of progestagens and Org OD14 in in vitro and in vivo tumor models J Steroid Biochem Mol Biol 49 1994 311 318